An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma/Experiment 3/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-23
Source: Figure 3a
Description: Differential microbial abundance in baseline gut microbiome between responders and nonresponders
Abundance in Group 1: decreased abundance in Responders to Immune checkpoint inhibitors
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella | ||
Alloprevotella sp. |
Revision editor(s): Mary Bearkland, Claregrieve1